Sun Pharmaceutical is introducing delayed-release pantoprazole oral suspension in a dosage strength of 40 mg. The product is the first generic of Pfizer’s Protonix oral delayed-release suspension 40 ...

NEW YORK — Two generic drugmakers will pay $2.15 billion to Pfizer and Takeda Pharmaceutical to settle a patent fight over the heartburn treatment Protonix. Teva Pharmaceutical Industries Ltd., one of ...

Aug 2 (Reuters) - Teva Pharmaceutical Industries Ltd. said the U.S. health regulators have approved its generic version of Wyeth's heartburn drug Protonix. On July 31, Wyeth and its partner Nycomed ...

Generic drug maker Teva Pharmaceutical said today the company has agreed to extend its deal with Madison-based Wyeth and its partner Altana Pharma AG not to market a generic version of heartburn drug ...

After Teva launched generic Protonix on Christmas Eve, fought with Wyeth about it, then made a surprise exit, we thought the drama was over. But this week we get another act, thanks to the the ...